Triggers to Initiate Androgen-Deprivation Therapy (ADT) in Prostate Cancer

Panelists Raoul S. Concepcion, MD; Ashley E. Ross, MD, PhD; Daniel R. Saltzstein, MD; Alicia K. Morgans, MD, MPH; and Jorge A. Garcia, MD, discuss the triggers to initiate androgen- deprivation therapy in prostate cancer, particularly in patients with biochemical recurrence.

Видео Triggers to Initiate Androgen-Deprivation Therapy (ADT) in Prostate Cancer канала OncLive